In silico analysis of Kemukus (Piper cubeba) as an antidyspeptic through inhibition of histamine H₂ receptors (3UZE)
Kata Kunci:
Piper cubeba, dyspepsia, histamine H₂ receptor, molecular docking, natural inhibitorsAbstrak
Dyspepsia is strongly associated with excessive gastric acid secretion mediated by histamine H₂ receptors. Natural products such as Piper cubeba have long been used to alleviate digestive disorders, yet their molecular mechanisms remain underexplored. This study aimed to evaluate the antidyspeptic potential of ten major compounds from P. cubeba through in silico docking against the histamine H₂ receptor structure (3UZE), with ranitidine as a positive control. Molecular docking was performed to predict binding affinity and interaction profiles within the receptor’s active site. Several cubeb constituents demonstrated favorable binding energies and key interactions comparable to the standard ligand, suggesting potential inhibitory activity. These findings provide preliminary evidence that P. cubeba bioactive compounds may act as histamine H₂ receptor modulators and support their further investigation as natural antidyspeptic candidates.
Referensi
L. C. Barbosa et al., ‘Chemopreventive effects of (-)-Hinokinin against 1,2-dimethylhydrazine-induced genotoxicity and preneoplastic lesions in rat colon’, J. Nat. Prod., vol. 77, no. 10, pp. 2312–2315, 2014, doi: 10.1021/np500093u.
X. He, B. Walker, V. H. Man, P. Ren, and J. Wang, ‘Recent progress in general force fields of small molecules’, Curr. Opin. Struct. Biol., vol. 72, pp. 187–193, 2022, doi: 10.1016/j.sbi.2021.11.011.
N. P. Qomaladewi, N. Aziz, M.-Y. Kim, and J. Y. Cho, ‘Piper cubeba L. Methanol Extract Has Anti-Inflammatory Activity Targeting Src/Syk via NF- κ B Inhibition’, Evidence-Based Complement. Altern. Med., vol. 2019, pp. 1–8, 2019.
C. Arruda, J. A. A. Mejía, V. Pena Ribeiro, L. Costa Oliveira, M. L. A. E Silva, and J. K. Bastos, ‘Development of a Validated High-Performance Liquid Chromatography Method and Optimization of the Extraction of Lignans from Piper cubeba’, J. Agric. Food Chem., vol. 67, no. 2, pp. 753–759, 2019, doi: 10.1021/acs.jafc.8b05359.
T. Usia, T. Watabe, S. Kadota, and Y. Tezuka, ‘Potent CYP3A4 inhibitory constituents of Piper cubeba’, J. Nat. Prod., vol. 68, no. 1, pp. 64–68, 2005, doi: 10.1021/np0401765.
G. A. Patrikeev, ‘Macromolecular mechanics’, Polym. Mech., vol. 7, no. 2, pp. 183–192, 1971, doi: 10.1007/BF00855851.
A. H. Shah, A. H. Al-Shareef, A. M. Ageel, and S. Qureshi, ‘Toxicity studies in mice of common spices, Cinnamomum zeylanicum bark and Piper longum fruits’, Plant Foods Hum. Nutr., vol. 52, no. 3, pp. 231–239, 1998, doi: 10.1023/A:1008088323164.
G. Singh, P. Marimuthu, C. S. D. Heluani, and C. A. N. Catalan, ‘Chemical constituents, antioxidative and antimicrobial activities of essential oil and oleoresin of tailed pepper (Piper Cubeba L)’, Int. J. Food Eng., vol. 3, no. 6, 2007, doi: 10.2202/1556-3758.1154.
I. K. Setyani, W. Wahyono, and T. N. S. Sulaiman, ‘Standardisasi Simplisia dan Ekstrak Buah Kemukus (Piper cubeba Lf.) Sebagai Bahan Baku Sediaan Kapsul Jamu Sesak Nafas’, JPSCR J. Pharm. Sci. Clin. Res., vol. 6, no. 3, p. 238, 2021, doi: 10.20961/jpscr.v6i3.50372.
L. Ruan, N. Jiang, F. Guo, H. Xu, J. Zhang, and J. Sun, ‘The antiresoptive effects of recombinant Lingzhi-8 protein against retinoic acid-induced osteopenia’, Eur. J. Pharmacol., vol. 863, no. September, 2019, doi: 10.1016/j.ejphar.2019.172669.
N. Eralita and S. Khuzaimah, ‘The Extraction of Essential Oil from Piper Cubeba by Using Solvent Free Microwave Extraction Method’, Eksakta Berk. Ilm. Bid. MIPA, vol. 21, no. 2, pp. 85–97, 2020, doi: 10.24036/eksakta/vol21-iss2/239.
P. Kumar, ‘A Review on Medicinal Plant Piper cubeba L. and Its Pharmaceutical Properties’, Int. J. Food Sci. Agric., vol. 5, no. 1, pp. 174–179, 2021, doi: 10.26855/ijfsa.2021.03.022.
T. Z. Abdul-Jalil and Z. A. Nasser, ‘Piper cubeba: Phytochemical and pharmacological review of a routinely used spices.’, Int. J. Pharm. Res., vol. 12, no. 1, pp. 761–768, 2020, doi: 10.31838/ijpr/2020.SP1.119.
B. Drissi, I. Mahdi, and M. Yassir, ‘Cubeb ( Piper cubeba L . f .): A comprehensive review of its botany , phytochemistry , traditional uses , and pharmacological properties’, Front. Nutr., no. November, pp. 1–25, 2022, doi: 10.3389/fnut.2022.1048520.
Y. Andriana, T. D. Xuan, T. N. Quy, H.-D. Tran, and Q.-T. Le, ‘Biological Activities and Chemical Constituents’, Molecules, pp. 1–16, 2019.
E. Solowey, M. Lichtenstein, S. Sallon, H. Paavilainen, E. Solowey, and H. Lorberboum-Galski, ‘Evaluating medicinal plants for anticancer activity’, Sci. World J., vol. 2014, 2014, doi: 10.1155/2014/721402.
M. W. Khan and R. A. Khan, ‘IN VITRO PHARMACOLOGICAL EFFECTS OF ASTRAGALUS EREMOPHILUS AND MELILOTUS’, vol. 69, no. 4, pp. 411–422, 2018, doi: 10.1556/018.69.2018.4.4.
M. Zahin, M. S. Khan, F. Abul Qais, H. H. Abulreesh, and I. Ahmad, ‘Antioxidant properties and anti-mutagenic potential of Piper Cubeba fruit extract and molecular docking of certain bioactive compounds’, Drug Chem. Toxicol., vol. 41, no. 3, pp. 358–367, 2018, doi: 10.1080/01480545.2018.1429459.
H. Gao, Y. Wu, J. Li, H. Li, J. Li, and R. Yang, ‘Forward LASSO analysis for high-order interactions in genome-wide association study’, Brief. Bioinform., vol. 15, no. 4, pp. 552–561, 2014, doi: 10.1093/bib/bbt037.
P. Graidist, M. Martla, and Y. Sukpondma, ‘Cytotoxic Activity of Piper cubeba Extract in Breast Cancer Cell Lines’, pp. 2707–2718, 2015, doi: 10.3390/nu7042707.
F. Alminderej, S. Bakari, T. I. Almundarij, M. Snoussi, K. Aouadi, and A. Kadri, ‘RETRACTED: Antimicrobial and Wound Healing Potential of a New Chemotype from Piper cubeba L. Essential Oil and In Silico Study on S. aureus tyrosyl-tRNA Synthetase Protein’, Plants, vol. 10, no. 2, pp. 1–20, 2021, doi: 10.3390/plants10020205.
E. Lionta, G. Spyrou, D. Vassilatis, and Z. Cournia, ‘Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances’, Curr. Top. Med. Chem., vol. 14, no. 16, pp. 1923–1938, 2014, doi: 10.2174/1568026614666140929124445.
T. M. G. Salerno, P. Donato, G. Frison, L. Zamengo, and L. Mondello, ‘Gas Chromatography—Fourier Transform Infrared Spectroscopy for Unambiguous Determination of Illicit Drugs: A Proof of Concept’, Front. Chem., vol. 8, no. July, pp. 1–12, 2020, doi: 10.3389/fchem.2020.00624.
R. Xia et al., ‘Cryo-EM structure of the human histamine H1 receptor/Gq complex’, Nat. Commun., vol. 12, no. 1, pp. 1–9, 2021, doi: 10.1038/s41467-021-22427-2.
A. K. Farha, ‘Anticancer activity studies of cubebin isolated from Piper cubeba and its synthetic derivatives’, no. March, pp. 2–7, 2016, doi: 10.1016/j.bmcl.2016.02.041.
A. A. Ishola, T. Joshi, S. I. Abdulai, H. Tijjani, H. Pundir, and S. Chandra, ‘Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19’, J. Biomol. Struct. Dyn., vol. 40, no. 13, pp. 5785–5802, 2022, doi: 10.1080/07391102.2021.1873191.
Z. Li et al., ‘Protective Activity of Cubebin from Syringa oblata Against CCl4-Induced Hepatic Damage in Mice’, Rev. Bras. Farmacogn., vol. 31, no. 3, pp. 322–329, 2021, doi: 10.1007/s43450-021-00171-4.
H. S. Bodiwala et al., ‘Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum’, J. Nat. Med., vol. 61, no. 4, pp. 418–421, 2007, doi: 10.1007/s11418-007-0159-2.
J. P. Gusson-Zanetoni et al., ‘Effect of Piper cubeba total extract and isolated lignans on head and neck cancer cell lines and normal fibroblasts’, J. Pharmacol. Sci., vol. 148, no. 1, pp. 93–102, 2022, doi: 10.1016/j.jphs.2021.09.002.
N. S. Pagadala, K. Syed, and J. Tuszynski, ‘Software for molecular docking: a review’, Biophys. Rev., vol. 9, no. 2, pp. 91–102, 2017, doi: 10.1007/s12551-016-0247-1.
G. Moroy, V. Y. Martiny, P. Vayer, B. O. Villoutreix, and M. A. Miteva, ‘Toward in silico structure-based ADMET prediction in drug discovery’, Drug Discov. Today, vol. 17, no. 1–2, pp. 44–55, 2012, doi: 10.1016/j.drudis.2011.10.023.
B. E. Drissi, I. Mahdi, A. Bu, and M. Sobeh, ‘Cubeb ( Piper cubeba L .): nutritional value , phytochemical profiling and dermacosmeceutical properties’, no. May, pp. 1–16, 2024, doi: 10.3389/fnut.2024.1352548.
M. Kržan, J. Keuschler, J. Mavri, and R. Vianello, ‘Relevance of hydrogen bonds for the histamine H2 receptor-ligand interactions: A lesson from deuteration’, Biomolecules, vol. 10, no. 2, pp. 2–11, 2020, doi: 10.3390/biom10020196.
V. M. A. S. Grinevicius, K. S. Andrade, F. Ourique, G. A. Micke, S. R. S. Ferreira, and R. C. Pedrosa, ‘Antitumor activity of conventional and supercritical extracts from Piper nigrum L. cultivar Bragantina through cell cycle arrest and apoptosis induction’, J. Supercrit. Fluids, vol. 128, pp. 94–101, 2017, doi: 10.1016/j.supflu.2017.05.009.
J. K. Lancia, A. Nwokoye, A. Dugan, C. Joiner, R. Pricer, and A. K. Mapp, ‘Sequence context and crosslinking mechanism affect the efficiency of in vivo capture of a protein-protein interaction’, Biopolymers, vol. 101, no. 4, pp. 391–397, 2014, doi: 10.1002/bip.22395.
A. M. Niwa et al., ‘Evaluation of lignan (-)-cubebin extracted from Piper cubeba on human colon adenocarcinoma cells (HT29)’, J. Toxicol. Environ. Heal. - Part A Curr. Issues, vol. 79, no. 2, pp. 92–100, 2016, doi: 10.1080/15287394.2015.1110067.
X. Peng et al., ‘Structural basis for recognition of antihistamine drug by human histamine receptor’, Nat. Commun., vol. 13, no. 1, 2022, doi: 10.1038/s41467-022-33880-y.
R. G. De Lima, T. Barros, and S. Laurentiz, ‘Medicinal Attributes of Lignans Extracted from Piper Cubeba : Current Developments’, pp. 180–191, 2018, doi: 10.1002/open.201700182.
F. Alqadeeri, Y. Rukayadi, F. Abbas, and K. Shaari, ‘Antibacterial and Antispore Activities of Isolated Compounds from Piper cubeba L.’, pp. 1–15, 2019.
M. Mulik and K. Laddha, ‘Isolation , characterization and quantification of bioactive dibenzylbutyrolactone lignan ( - ) -cubebin from fruits of Piper cubeba L . f .’, no. October, 2015.
L. Pinzi and G. Rastelli, ‘Molecular docking: Shifting paradigms in drug discovery’, Int. J. Mol. Sci., vol. 20, no. 18, 2019, doi: 10.3390/ijms20184331.
A. Azminah, L. Erlina, M. Radji, A. Mun’im, R. R. Syahdi, and A. Yanuar, ‘In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database’, Comput. Biol. Chem., vol. 83, no. June, p. 107096, 2019, doi: 10.1016/j.compbiolchem.2019.107096.
G. Madhavi Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, and W. Sherman, ‘Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments’, J. Comput. Aided. Mol. Des., vol. 27, no. 3, pp. 221–234, 2013, doi: 10.1007/s10822-013-9644-8.
M. A. Azam, F. M. Alias, L. W. Tack, R. N. A. R. Seman, and M. F. M. Taib, ‘Electronic properties and gas adsorption behaviour of pristine, silicon-, and boron-doped (8, 0) single-walled carbon nanotube: A first principles study’, J. Mol. Graph. Model., vol. 75, pp. 85–93, 2017, doi: 10.1016/j.jmgm.2017.05.003.
T. Z. Abdul-jalil and Z. A. Nasser, ‘Piper cubeba : phytochemical and pharmacological review of a routinely used spices .’, no. November, 2020, doi: 10.31838/ijpr/2020.SP1.119.
C. Arruda, J. A. A. Mejía, V. Pena Ribeiro, L. Costa Oliveira, M. L. A. e Silva, and J. K. Bastos, ‘Development of a Validated High-Performance Liquid Chromatography Method and Optimization of the Extraction of Lignans from Piper cubeba’, J. Agric. Food Chem., vol. 67, no. 2, pp. 753–759, Jan. 2019, doi: 10.1021/acs.jafc.8b05359.
L. G. Ferreira, R. N. Dos Santos, G. Oliva, and A. D. Andricopulo, Molecular docking and structure-based drug design strategies, vol. 20, no. 7. 2015. doi: 10.3390/molecules200713384.
M. A. Azam, F. M. Alias, L. W. Tack, R. N. A. R. Seman, and M. F. M. Taib, ‘Electronic properties and gas adsorption behaviour of pristine, silicon-, and boron-doped (8, 0) single-walled carbon nanotube: A first principles study’, J. Mol. Graph. Model., vol. 75, pp. 85–93, 2017, doi: https://doi.org/10.1016/j.jmgm.2017.05.003.
W. Thiel, ‘Max-Planck-Institut für Kohlenforschung Semiempirical quantum-chemical methods’, vol. 157, pp. 145–157, 2014.
X. He, B. Walker, V. H. Man, P. Ren, and J. Wang, ‘Recent progress in general force fields of small molecules’, Curr. Opin. Struct. Biol., vol. 72, pp. 187–193, 2022, doi: 10.1016/j.sbi.2021.11.011.
